Literature DB >> 16619186

Suppression of prostaglandin E2 by malaria parasite products and antipyretics promotes overproduction of tumor necrosis factor-alpha: association with the pathogenesis of childhood malarial anemia.

Christopher C Keller1, Gregory C Davenport, Katherine R Dickman, James B Hittner, Sandra S Kaplan, J Brice Weinberg, Peter G Kremsner, Douglas J Perkins.   

Abstract

Cytokines and effector molecules are important immunoregulatory molecules in human malaria. Tumor necrosis factor (TNF)-alpha limits malaria parasitemia but also promotes pathogenesis at high concentrations, whereas prostaglandin E2 (PGE2) inhibits TNF-alpha production and is reduced in childhood malaria, at least in part, through suppression of cyclooxygenase (COX)-2 following the ingestion of Plasmodium falciparum hemozoin (pfHz; malarial pigment) by peripheral blood mononuclear cells (PBMCs). Although molecular interactions between TNF-alpha and PGE2 are largely unexplored in human malaria, results presented here show that pfHz-induced suppression of PBMC COX-2 gene products induces overproduction of TNF-alpha. Moreover, addition of exogenous PGE2 to pfHz-treated PBMCs dose-dependently decreased TNF-alpha production, whereas experimental COX inhibitors and antipyretics used during human malaria generated increased TNF-alpha production. Healthy, malaria-exposed children had elevated levels of circulating bicyclo-PGE2/TNF-alpha, compared with children with malarial anemia (P<.01), with systemic bicyclo-PGE2 and TNF-alpha significantly associated with hemoglobin concentrations (r=0.745; P<.01). The results of the present study illustrate that pfHz-induced suppression of PGE2 promotes overproduction of TNF-alpha, which is associated with enhanced malarial anemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16619186     DOI: 10.1086/503047

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemia.

Authors:  Collins Ouma; Christopher C Keller; Gregory C Davenport; Tom Were; Stephen Konah; Michael F Otieno; James B Hittner; John M Vulule; Jeremy Martinson; John M Ong'echa; Robert E Ferrell; Douglas J Perkins
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

2.  Reduced systemic bicyclo-prostaglandin-E2 and cyclooxygenase-2 gene expression are associated with inefficient erythropoiesis and enhanced uptake of monocytic hemozoin in children with severe malarial anemia.

Authors:  Samuel B Anyona; Prakasha Kempaiah; Evans Raballah; Gregory C Davenport; Tom Were; Stephen N Konah; John M Vulule; James B Hittner; Charity W Gichuki; John M Ong'echa; Douglas J Perkins
Journal:  Am J Hematol       Date:  2012-06-23       Impact factor: 10.047

3.  Suppressed circulating bicyclo-PGE2 levels and leukocyte COX-2 transcripts in children co-infected with P. falciparum malaria and HIV-1 or bacteremia.

Authors:  Samuel B Anyona; Prakasha Kempaiah; Gregory C Davenport; John M Vulule; James B Hittner; John M Ong'echa; Douglas J Perkins
Journal:  Biochem Biophys Res Commun       Date:  2013-06-03       Impact factor: 3.575

4.  Acquisition of hemozoin by monocytes down-regulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: in vivo and in vitro findings in severe malarial anemia.

Authors:  Christopher C Keller; Ouma Yamo; Collins Ouma; John Michael Ong'echa; David Ounah; James B Hittner; John M Vulule; Douglas J Perkins
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

5.  The roles of betulinic acid on circulating concentrations of creatine kinase and immunomodulation in mice infected with chloroquine-susceptible and resistant strains of Plasmodium berghei.

Authors:  John Oludele Olanlokun; Praise Oghenegare Okoro; Olufunso Olabode Olorunsogo
Journal:  J Parasit Dis       Date:  2021-07-31

6.  Prognostic value of circulating pigmented cells in African children with malaria.

Authors:  Peter Gottfried Kremsner; Clarissa Valim; Michel A Missinou; Christopher Olola; Sanjeev Krishna; Saadou Issifou; Maryvonne Kombila; Lloyd Bwanaisa; Sadik Mithwani; Charles R Newton; Tsiri Agbenyega; Margaret Pinder; Kalifa Bojang; David Wypij; Terrie Taylor
Journal:  J Infect Dis       Date:  2009-01-01       Impact factor: 5.226

7.  Increased circulating interleukin (IL)-23 in children with malarial anemia: in vivo and in vitro relationship with co-regulatory cytokines IL-12 and IL-10.

Authors:  John M Ong'echa; Allison M Remo; Jan Kristoff; James B Hittner; Tom Were; Collins Ouma; Richard O Otieno; John M Vulule; Christopher C Keller; Gordon A Awandare; Douglas J Perkins
Journal:  Clin Immunol       Date:  2007-10-22       Impact factor: 3.969

8.  Suppression of a novel hematopoietic mediator in children with severe malarial anemia.

Authors:  Christopher C Keller; Collins Ouma; Yamo Ouma; Gordon A Awandare; Gregory C Davenport; Tom Were; James B Hittner; John M Vulule; John M Ong'echa; Douglas J Perkins
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

9.  Immune activation and regulation in simian immunodeficiency virus-Plasmodium fragile-coinfected rhesus macaques.

Authors:  Kristin A Trott; Amy Richardson; Michael A Hudgens; Kristina Abel
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

Review 10.  Severe malarial anemia: innate immunity and pathogenesis.

Authors:  Douglas J Perkins; Tom Were; Gregory C Davenport; Prakasha Kempaiah; James B Hittner; John Michael Ong'echa
Journal:  Int J Biol Sci       Date:  2011-11-02       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.